enkephalin-leu--ala(2)-arg(6)- has been researched along with Hypertension* in 2 studies
2 other study(ies) available for enkephalin-leu--ala(2)-arg(6)- and Hypertension
Article | Year |
---|---|
[The functional status of the sympathoadrenal system in hypertension patients being treated with captopril and dalargin].
The level of urinary excretion of catecholamines (CA) and their precursors was studied in 87 patients with stage I, II hypertensive disease (HD). Three groups were formed depending on the therapy option: group I comprised stage I HD patients in whom endonasal dalargin electrophoresis (EDE) was instituted, groups II and III were patients with stage II HD who were given a complex therapy with captopril plus EDE and monotherapy with captopril respectively. EDE led to a decline in the functional activity of the sympathoadrenal system (SAS) in stage I HD patients and potentiated a hypotensive effect of captopril resulting in diminution of excretion of norepinephrine. Captopril monotherapy failed to have an effect on the SAS condition. Topics: Adrenal Glands; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Drug Synergism; Drug Therapy, Combination; Enkephalin, Leucine-2-Alanine; Humans; Hypertension; Middle Aged; Sympathetic Nervous System | 1999 |
[Results of the use of dalargin electrophoresis to correct mental disorders in patients with hypertension grades I and II].
Dalargin, a small regulatory peptide produced in the USSR was tested with respect to its effect on psychological indices in 80 patients with essential hypertension grades I and II. Endonasal Dalargin electrophoresis was applied in 50 patients and 30 were subjected to endonasal galvanization (the control group). Electrophoretically applied Dalargin was shown to accelerate the sensorimotor responses, improve memory, reduce the anxiety levels. Topics: Adult; Anxiety Disorders; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Female; Humans; Hypertension; Iontophoresis; Male; Memory Disorders; Middle Aged; Neurocognitive Disorders; Psychomotor Performance | 1989 |